Suppr超能文献

与非酒精性脂肪性肝病(NAFLD)中组织学与 MRI-PDFF 检测的肝脂肪变程度不一致相关的临床和组织学因素。

Clinical and histologic factors associated with discordance between steatosis grade derived from histology vs. MRI-PDFF in NAFLD.

机构信息

NAFLD Research Center, Division of Gastroenterology and Hepatology, Department of Medicine, University of California, San Diego, California, USA.

Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.

出版信息

Aliment Pharmacol Ther. 2023 Jul;58(2):229-237. doi: 10.1111/apt.17564. Epub 2023 Jun 2.

Abstract

BACKGROUND

Magnetic resonance imaging-proton density fat fraction (MRI-PDFF) is an excellent biomarker for the non-invasive quantification of hepatic steatosis.

AIM

To examine clinical and histologic factors associated with discordance between steatosis grade determined by histology and MRI-PDFF in patients with non-alcoholic fatty liver disease (NAFLD) METHODS: We included 728 patients with biopsy-proven NAFLD from UC San Diego (n = 414) and Yokohama City University (n = 314) who underwent MRI-PDFF and liver biopsy. Patients were stratified by steatosis, and matched with MRI-PDFF cut-points for each steatosis grade: 0 (MRI-PDFF < 6.4%), 1 (MRI-PDFF: 6.4%-17.4%), 2 (MRI-PDFF: 17.4%-22.1%), 3 (MRI-PDFF ≥ 22.1%). Primary outcome was major discordance defined as ≥2 steatosis grade difference determined by histology and MRI-PDFF.

RESULTS

Mean (±SD) age and BMI were 55.3 (±13.8) years and 29.9 (±4.9) kg/m , respectively. The distributions of histology and MRI-PDFF-determined steatosis were 5.5% grade 0 (n = 40), 44.8% 1 (n = 326, 44.8%), 33.9% 2 (n = 247), and 15.8% 3 (n = 115) vs. 23.5% grade 0 (n = 171), 49.7% 1 (n = 362), 12.9% 2 (n = 94), and 13.9% 3 (n = 101). Major discordance rate was 6.6% (n = 48). Most cases with major discordance had greater histology-determined steatosis grade (n = 40, 88.3%), higher serum AST and liver stiffness, and greater likelihood of fibrosis ≥2, ballooning ≥1 and lobular inflammation ≥2 (all p < 0.05).

CONCLUSION

Histology overestimates steatosis grade compared to MRI-PDFF. Patients with advanced NASH are likely to be upgraded on steatosis grade by histology. These data have important implications for steatosis estimation and reporting on histology in clinical practice and trials, especially in patients with stage 2 fibrosis.

摘要

背景

磁共振质子密度脂肪分数(MRI-PDFF)是一种出色的生物标志物,可用于无创定量肝脂肪变性。

目的

检查与非酒精性脂肪性肝病(NAFLD)患者肝活检确定的脂肪变性程度与 MRI-PDFF 之间不一致相关的临床和组织学因素。

方法

我们纳入了来自加利福尼亚大学圣地亚哥分校(n=414)和横滨市立大学(n=314)的 728 名经活检证实的 NAFLD 患者,他们接受了 MRI-PDFF 和肝活检。根据脂肪变性程度对患者进行分层,并与每个脂肪变性等级的 MRI-PDFF 切点相匹配:0(MRI-PDFF<6.4%)、1(MRI-PDFF:6.4%-17.4%)、2(MRI-PDFF:17.4%-22.1%)、3(MRI-PDFF≥22.1%)。主要结局是由组织学和 MRI-PDFF 确定的脂肪变性程度差异≥2 级的主要差异。

结果

平均(±SD)年龄和 BMI 分别为 55.3(±13.8)岁和 29.9(±4.9)kg/m2。组织学和 MRI-PDFF 确定的脂肪变性分布为 5.5%为 0 级(n=40)、44.8%为 1 级(n=326,44.8%)、33.9%为 2 级(n=247)和 15.8%为 3 级(n=115),而 23.5%为 0 级(n=171)、49.7%为 1 级(n=362)、12.9%为 2 级(n=94)和 13.9%为 3 级(n=101)。主要差异率为 6.6%(n=48)。大多数主要差异病例的组织学确定的脂肪变性等级更高(n=40,88.3%),血清 AST 和肝硬度更高,纤维化≥2 级、气球样变≥1 级和肝小叶炎症≥2 级的可能性更大(均 P<0.05)。

结论

与 MRI-PDFF 相比,组织学高估了脂肪变性程度。患有晚期 NASH 的患者其脂肪变性等级可能通过组织学检查得到升级。这些数据对临床实践和试验中脂肪变性的估计和报告具有重要意义,尤其是在 2 级纤维化的患者中。

相似文献

1
Clinical and histologic factors associated with discordance between steatosis grade derived from histology vs. MRI-PDFF in NAFLD.
Aliment Pharmacol Ther. 2023 Jul;58(2):229-237. doi: 10.1111/apt.17564. Epub 2023 Jun 2.
9
Correlations Between MRI Biomarkers PDFF and cT1 With Histopathological Features of Non-Alcoholic Steatohepatitis.
Front Endocrinol (Lausanne). 2021 Jan 27;11:575843. doi: 10.3389/fendo.2020.575843. eCollection 2020.

引用本文的文献

2
Metabolic dysfunction-associated steatotic liver disease in adults.
Nat Rev Dis Primers. 2025 Mar 6;11(1):14. doi: 10.1038/s41572-025-00599-1.
3
The association between vitamin E intake and hepatic steatosis in general and obese populations.
Nutr Metab (Lond). 2024 Jul 30;21(1):57. doi: 10.1186/s12986-024-00830-y.

本文引用的文献

1
Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis.
Gut. 2023 Mar;72(3):581-589. doi: 10.1136/gutjnl-2022-327777. Epub 2022 Sep 9.
2
Clinical Utility of Combined MRI-PDFF and ALT Response in Predicting Histologic Response in Nonalcoholic Fatty Liver Disease.
Clin Gastroenterol Hepatol. 2023 Sep;21(10):2682-2685.e4. doi: 10.1016/j.cgh.2022.08.036. Epub 2022 Sep 6.
3
Global burden of liver cancer in males and females: Changing etiological basis and the growing contribution of NASH.
Hepatology. 2023 Apr 1;77(4):1150-1163. doi: 10.1002/hep.32758. Epub 2022 Sep 12.
4
Shared Mechanisms between Cardiovascular Disease and NAFLD.
Semin Liver Dis. 2022 Nov;42(4):455-464. doi: 10.1055/a-1930-6658. Epub 2022 Aug 25.
5
Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer.
Cell Metab. 2022 Jul 5;34(7):969-977.e2. doi: 10.1016/j.cmet.2022.05.003. Epub 2022 Jun 3.
6
Impact of non-invasive biomarkers on hepatology practice: Past, present and future.
J Hepatol. 2022 Jun;76(6):1362-1378. doi: 10.1016/j.jhep.2022.03.026.
8
Expert Panel Review to Compare FDA and EMA Guidance on Drug Development and Endpoints in Nonalcoholic Steatohepatitis.
Gastroenterology. 2022 Mar;162(3):680-688. doi: 10.1053/j.gastro.2021.10.051. Epub 2021 Nov 23.
9
Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD.
Nat Rev Endocrinol. 2022 Jan;18(1):55-66. doi: 10.1038/s41574-021-00584-0. Epub 2021 Nov 23.
10
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease.
Clin Mol Hepatol. 2021 Jul;27(3):363-401. doi: 10.3350/cmh.2021.0178. Epub 2021 Jun 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验